Silence Therapeutics (SLN) Research & Development (2024 - 2026)
Silence Therapeutics (SLN) reported Research & Development of $9.1 million for Q1 2026, down 56.17% on a YoY basis from $20.8 million in Q1 2025, and up 1415.28% sequentially from $602000.0 in Q4 2025.
Silence Therapeutics (SLN) Research & Development (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of Research & Development data on file, last reported at $9.1 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 56.17% year-over-year to $9.1 million; the trailing twelve-month figure through Mar 2026 stood at $23.8 million (down 66.0% YoY), and the FY2025 full-year result was $4.8 million, down 92.94% from the prior year.
- Research & Development rose to $9.1 million in Q1 2026, from $602000.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $40.2 million in Q4 2024 to a low of $602000.0 in Q4 2025.
- A 3-year average of $10.5 million and a median of $7.8 million in 2024 frame the typical range for Research & Development.
- Peak annual rise in Research & Development reached 3224.76% in 2025, while the deepest fall reached 98.5% in 2025.
- Tracing SLN's Research & Development over 3 years: stood at $40.2 million in 2024, then plunged by 98.5% to $602000.0 in 2025, then surged by 1415.28% to $9.1 million in 2026.
- Business Quant data shows SLN's Research & Development at $9.1 million in Q1 2026, $602000.0 in Q4 2025, and $13.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | 9.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.12 Mn |
| Dec 31, 2025 | 602,000.00 |
| Sep 30, 2025 | 13.15 Mn |
| Jun 30, 2025 | 936,000.00 |
| Mar 31, 2025 | 20.81 Mn |
| Dec 31, 2024 | 40.17 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 7.77 Mn |
| Mar 31, 2024 | 626,000.00 |